ArticleOrthopaedic journal of sports medicine2026
Functional and Analgesic Effects of iPACK Blocks Added to Continuous Adductor Canal Blocks for ACL Reconstruction With Quadriceps Tendon Autograft: A Randomized Controlled Trial.
Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05498870 (Studying the Effects of iPACK Blocks With Adductor Canal Blocks for Postoperative Analgesia Following ACL Reconstruction), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Studying the Effects of iPACK Blocks With Adductor Canal Blocks for Postoperative Analgesia Following ACL Reconstruction
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: An adjunctive infiltration between popliteal artery and capsule of the posterior knee (iPACK) block-an infiltration between the popliteal artery and posterior knee capsule-has been used in knee surgery to address posterior knee pain, complementing the anterior and medial sensory coverage of an adductor canal block (ACB). Its benefit in all-inside anterior cruciate ligament reconstruction (ACL-R) using quadriceps tendon (QT) autograft remains uncertain. Purpose: To compare acute postoperative pain, opioid consumption, and 6-week knee range of motion between patients receiving continuous ACB alone and continuous ACB plus a single-shot iPACK block. Study Design: Randomized controlled trial; Level of evidence, 2. Methods: Patients undergoing primary all-inside ACL-R with QT autograft were randomized to either continuous ACB with placebo skin wheal (ACB group) or continuous ACB with iPACK (ACB-iPACK group). Demographic and surgical data were collected prospectively. The primary outcome was visual analog scale (VAS) pain scores during the first 72 postoperative hours. Secondary outcomes included opioid use (morphine milligram equivalents), achievement of full knee extension, and difference in maximal flexion between the surgical and nonsurgical limb at 6 weeks. Results: A total of 71 patients were analyzed (ACB, n = 33; ACB-iPACK, n = 38), with no significant group differences in baseline characteristics. Median VAS scores at discharge were significantly lower in the ACB-iPACK group (20 mm) versus the ACB group (32.5 mm) ( Conclusion: Adding an iPACK block to continuous ACB for all-inside ACL-R with QT autograft provided a slight reduction in pain at discharge (VAS difference, 12.5 mm) and improved knee flexion at 6 weeks. However, pain scores and opioid use beyond the immediate postoperative period were not significantly different between groups. These findings may help guide patient counseling regarding the expected benefits of incorporating an iPACK block in this surgical setting. Registration: NCT05498870 (ClinicalTrials.gov identifier).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.